Semma Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $937M

  • Investors
  • 2

Semma Therapeutics General Information

Description

Operator of a cell therapy and biotechnology company intended to develop transformative therapy with the curative use of stem cells in regenerative medicines. The company specializes in developing cell-based therapies for type 1 diabetes patients which traditionally require the use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device, thereby eliminating the use of insulin injections and providing a functional cure for patients with diabetes.

Contact Information

Website
www.semma-tx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Technology Square
  • Floor 3
  • Cambridge, MA 02139
  • United States
+1 (857)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertex Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 100 Technology Square
  • Floor 3
  • Cambridge, MA 02139
  • United States
+1 (857)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Semma Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 10-Oct-2019 $937M Completed Generating Revenue
4. Early Stage VC (Series B) 30-Nov-2017 Completed Startup
3. Grant 12-Sep-2016 Completed Startup
2. Early Stage VC (Series A) 24-Mar-2015 $44M $44M Completed Startup
1. University Spin-Out 01-Dec-2014 Completed Startup
To view Semma Therapeutics’s complete valuation and funding history, request access »

Semma Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Semma Therapeutics’s complete cap table history, request access »

Semma Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a cell therapy and biotechnology company intended to develop transformative therapy with the curative use of
Biotechnology
Cambridge, MA

London, Canada
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Semma Therapeutics Competitors (65)

One of Semma Therapeutics’s 65 competitors is Sernova, a Corporation company based in London, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sernova Corporation London, Canada
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA
Seraxis Venture Capital-Backed Germantown, MD
Mesoblast Corporation Melbourne, Australia
NeuroNascent Venture Capital-Backed Clarksville, MD
You’re viewing 5 of 65 competitors. Get the full list »

Semma Therapeutics Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
6 Dimensions Capital Venture Capital Minority
ARCH Venture Partners Venture Capital Minority
California Institute for Regenerative Medicine Government
Cowen Healthcare Investments Venture Capital Minority
Eight Roads Corporate Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Semma Therapeutics Acquisitions (1)

Semma Therapeutics’s most recent deal was a Merger/Acquisition with CytoSolv. The deal was made on 16-Nov-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CytoSolv 16-Nov-2015 Merger/Acquisition Biotechnology
To view Semma Therapeutics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Semma Therapeutics FAQs

  • When was Semma Therapeutics founded?

    Semma Therapeutics was founded in 2014.

  • Where is Semma Therapeutics headquartered?

    Semma Therapeutics is headquartered in Cambridge, MA.

  • What industry is Semma Therapeutics in?

    Semma Therapeutics’s primary industry is Biotechnology.

  • Is Semma Therapeutics a private or public company?

    Semma Therapeutics is a Private company.

  • What is the current valuation of Semma Therapeutics?

    The current valuation of Semma Therapeutics is .

  • What is Semma Therapeutics’s current revenue?

    The current revenue for Semma Therapeutics is .

  • How much funding has Semma Therapeutics raised over time?

    Semma Therapeutics has raised $158M.

  • Who are Semma Therapeutics’s investors?

    6 Dimensions Capital, ARCH Venture Partners, California Institute for Regenerative Medicine, Cowen Healthcare Investments, and Eight Roads are 5 of 14 investors who have invested in Semma Therapeutics.

  • Who are Semma Therapeutics’s competitors?

    Sernova, Neurona Therapeutics, Seraxis, Mesoblast, and NeuroNascent are some of the 65 competitors of Semma Therapeutics.

  • When was Semma Therapeutics acquired?

    Semma Therapeutics was acquired on 10-Oct-2019.

  • Who acquired Semma Therapeutics?

    Semma Therapeutics was acquired by Vertex Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »